Raj Pamnani and Cognition Life Science, Inc. recently announced the appointment of Dr Gregory L. Smith PHD as their new Director of Medical Affairs.

Dr Smith will act as Medical Advisor for the Florida based company, who developing proprietary formulations to treat major medical conditions such as Sleep Apnea and Alzheimer’s Disease.

Dr Smith’s recruitment is the latest in a series of coups for Cognition Life Science, Inc. who have recently made several high-profile acquisitions such as Dr William H Frey II and Eric J.Kezirian MD, MPH as scientific advisors.

Cognition Life Science, Inc. utilizes two approaches to achieve success:-

1.They look to collaborate with researchers and institutes developing novel formulations which address markets with annual or potential sales of over $1 billion.

2.They cross-reference generic drugs and expired patents to find compounds which are intended to reach the brain, with an objective to reformulate with intranasal delivery.

Cognition Life Science have already identified two prescription (Rx) drugs which meet their criteria.

About Dr Gregory L. Smith

Dr. Gregory Smith graduated with a medical degree from Rush Medical School in Chicago, and a Masters of Public Health from Harvard University.

Dr Smith completed residency training in Preventive Medicine at Walter Reed Army Medical Center, leaving the US Army with the rank of Major.

For the last 25 years, Doctor Smith has been in primary care practice in California, Georgia and Florida.

Dr Smith is a published author of two medical textbooks, a fiction novel (“Malpractice”), and a multitude of peer-reviewed medical publications and magazine articles.

Dr Smith is also a Director of Medical Affairs for CBC Biotechnologies, Inc. and First Harvest Financial, Inc.

About Raj Pamnani

Raj Pamnani has a wealth of experience in the capital markets and focused on corporate finance, mergers and acquisitions, investment banking, and structuring bridge and mezzanine financings in the healthcare and information technology sectors.

Raj Pamnani has considerable business development experience and was instrumental in bringing several biotechnology companies public in the late 1980s and early 1990s, including:-

  • Medarex (NASDAQ: MEDX)
  • Zonagen (ZONA)
  • Texas Biotechnology (TXB)
  • Ariad Pharmaceuticals (ARIA)
  • SciClone Pharmaceuticals (SCLN)


About Cognition Life Science, Inc:

Cognition Life Science, Inc. is a pharmaceutical company from Tampa, Florida.

Their mission is to explore, acquire and develop proprietary formulations to treat major pervasive medical conditions and diseases such as:

  •  Sleep Disorders such as Sleep Apnea
  •  Neurodegenerative diseases such as Alzheimer’s
  •  Mental Acuity
  •  Pain Management


Cognition Life Science have discovered a pharmaceutical product in the form of a pill that will cure Sleep Apnea, which will change the way the disease is treated.

Cognition Life Science are also currently involved with research trials of Cognizol, a THC-based nasal spray for Alzheimer’s disease.